MedTrace Logo

Repetitive Transcranial Magnetic Stimulation in Traumatic Brain Injury

NCT04573413 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2022-02-16

No results posted yet for this study

Summary

Randomized Controlled Trial (RCT) aiming at assessing the efficacy of a novel rehabilitation protocol, based on repetitive transcranial magnetic stimulation (r- TMS) in combination with a conventional cognitive treatment (CCT). The protocol will be statistically compared to the same CTT administered without the r-TMS in a sample of traumatic brain injury patients (age between 18 and 80 years) with left hemispatial Neglect.

Conditions

Interventions

DEVICE

Inhibitory repetitive transcranial magnetic stimulation

r-TMS Parameters: International 10/20 system for the location of the target area (left parietal cortex) 60% Power Frequency: 1 Hz 90 pulse trains with 10 pulses each (total 900 stimuli), resulted in a total stimulation period of 15 minutes. Visual Scanning Visual-spatial training; Reading and copying training; Copying of line drawings on a dot matrix. Barrage

DEVICE

Sham Group

Sham stimulation and Visual scanning training Intervention: Device: SHAM

Sponsors & Collaborators

  • Fabio La Porta

    collaborator UNKNOWN

  • Francesco Di Gregorio

    collaborator UNKNOWN

  • Roberto Piperno

    collaborator UNKNOWN

  • Emanuela Casanova

    collaborator UNKNOWN

  • Azienda Usl di Bologna

    lead OTHER_GOV

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-30
Primary Completion
2023-01-30
Completion
2023-03-30

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04573413 on ClinicalTrials.gov